-
Something wrong with this record ?
Coexistence of Clostridioides difficile and Staphylococcus aureus in gut of Iranian outpatients with underlying inflammatory bowel disease
M. Azimirad, M. Krutova, H. Balaii, M. Kodori, S. Shahrokh, O. Azizi, A. Yadegar, HA. Aghdaei, MR. Zali,
Language English Country Great Britain
Document type Journal Article
- MeSH
- Anti-Bacterial Agents pharmacology MeSH
- Biopsy MeSH
- Clostridioides difficile * drug effects MeSH
- Child MeSH
- Adult MeSH
- Feces microbiology MeSH
- Inflammatory Bowel Diseases diagnosis epidemiology etiology MeSH
- Coinfection complications microbiology MeSH
- Infant MeSH
- Middle Aged MeSH
- Humans MeSH
- Microbial Sensitivity Tests MeSH
- Adolescent MeSH
- Young Adult MeSH
- Disease Susceptibility MeSH
- Public Health Surveillance MeSH
- Outpatients * MeSH
- Child, Preschool MeSH
- Prevalence MeSH
- Aged MeSH
- Staphylococcus aureus * drug effects MeSH
- Intestinal Mucosa microbiology pathology MeSH
- Check Tag
- Child MeSH
- Adult MeSH
- Infant MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Male MeSH
- Child, Preschool MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Iran MeSH
Clostridioides difficile and Staphylococcus aureus are two well-known pathogens both causing hospital- and community-acquired infections. However, their intestinal coexistence was not well investigated in inflammatory bowel disease (IBD). Herein, we explored the prevalence of C. difficile, S. aureus and their coexistence in the gut of Iranian patients with IBD. Fecal and colon specimens were obtained from 70 outpatients with underlying IBD, and investigated for the presence of C. difficile and S. aureus. C. difficile isolates were characterised by CE-ribotyping. PCR was used for detection of toxin-encoding genes of C. difficile and S. aureus isolates. The antimicrobial susceptibility testing of C. difficile and S. aureus isolates were examined by agar dilution and Kirby-Bauer disk diffusion methods, respectively. Totally, C. difficile and S. aureus were detected in only 5.7% and 15.8% of IBD flares. Coexistence of C. difficile and S. aureus was detected in 5.7% of IBD flares. Two different C. difficile ribotypes including RT 126 and RT 017 were identified showing toxin profiles of tcdA+B+/cdtA+B+ and tcdA+B+, respectively. In S. aureus isolates, only positivity for the presence of sea enterotoxin was detected. C. difficile isolates were susceptible to metronidazole, ceftazidime and fidaxomicin. The highest resistance of S. aureus isolates was observed against penicillin (92.3%), following amoxicillin-clavulanate (38.5%) and amikacin (30.8%). Our findings demonstrated that patients with IBD flare are more sensitive to acquire coinfection of C. difficile and S. aureus than remission. However, more robust data is required to study the crosstalk between these enteric infections and their clinical relevance in patients with IBD flare.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20028534
- 003
- CZ-PrNML
- 005
- 20210114154154.0
- 007
- ta
- 008
- 210105s2020 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.anaerobe.2019.102113 $2 doi
- 035 __
- $a (PubMed)31698044
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Azimirad, Masoumeh $u Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- 245 10
- $a Coexistence of Clostridioides difficile and Staphylococcus aureus in gut of Iranian outpatients with underlying inflammatory bowel disease / $c M. Azimirad, M. Krutova, H. Balaii, M. Kodori, S. Shahrokh, O. Azizi, A. Yadegar, HA. Aghdaei, MR. Zali,
- 520 9_
- $a Clostridioides difficile and Staphylococcus aureus are two well-known pathogens both causing hospital- and community-acquired infections. However, their intestinal coexistence was not well investigated in inflammatory bowel disease (IBD). Herein, we explored the prevalence of C. difficile, S. aureus and their coexistence in the gut of Iranian patients with IBD. Fecal and colon specimens were obtained from 70 outpatients with underlying IBD, and investigated for the presence of C. difficile and S. aureus. C. difficile isolates were characterised by CE-ribotyping. PCR was used for detection of toxin-encoding genes of C. difficile and S. aureus isolates. The antimicrobial susceptibility testing of C. difficile and S. aureus isolates were examined by agar dilution and Kirby-Bauer disk diffusion methods, respectively. Totally, C. difficile and S. aureus were detected in only 5.7% and 15.8% of IBD flares. Coexistence of C. difficile and S. aureus was detected in 5.7% of IBD flares. Two different C. difficile ribotypes including RT 126 and RT 017 were identified showing toxin profiles of tcdA+B+/cdtA+B+ and tcdA+B+, respectively. In S. aureus isolates, only positivity for the presence of sea enterotoxin was detected. C. difficile isolates were susceptible to metronidazole, ceftazidime and fidaxomicin. The highest resistance of S. aureus isolates was observed against penicillin (92.3%), following amoxicillin-clavulanate (38.5%) and amikacin (30.8%). Our findings demonstrated that patients with IBD flare are more sensitive to acquire coinfection of C. difficile and S. aureus than remission. However, more robust data is required to study the crosstalk between these enteric infections and their clinical relevance in patients with IBD flare.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a antibakteriální látky $x farmakologie $7 D000900
- 650 _2
- $a biopsie $7 D001706
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a předškolní dítě $7 D002675
- 650 12
- $a Clostridioides difficile $x účinky léků $7 D016360
- 650 _2
- $a koinfekce $x komplikace $x mikrobiologie $7 D060085
- 650 _2
- $a náchylnost k nemoci $7 D004198
- 650 _2
- $a feces $x mikrobiologie $7 D005243
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a idiopatické střevní záněty $x diagnóza $x epidemiologie $x etiologie $7 D015212
- 650 _2
- $a střevní sliznice $x mikrobiologie $x patologie $7 D007413
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a pacienti ambulantní $7 D010045
- 650 _2
- $a prevalence $7 D015995
- 650 _2
- $a ochrana veřejného zdraví $7 D062486
- 650 12
- $a Staphylococcus aureus $x účinky léků $7 D013211
- 650 _2
- $a mladý dospělý $7 D055815
- 651 _2
- $a Írán $x epidemiologie $7 D007492
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Krutova, Marcela $u Department of Medical Microbiology, Charles University in Prague, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic.
- 700 1_
- $a Balaii, Hedieh $u Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- 700 1_
- $a Kodori, Mansoor $u Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- 700 1_
- $a Shahrokh, Shabnam $u Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- 700 1_
- $a Azizi, Omid $u Department of Laboratory Sciences, School of Paramedical Sciences, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran.
- 700 1_
- $a Yadegar, Abbas $u Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: a.yadegar@sbmu.ac.ir.
- 700 1_
- $a Aghdaei, Hamid Asadzadeh $u Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- 700 1_
- $a Zali, Mohammad Reza $u Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- 773 0_
- $w MED00006567 $t Anaerobe $x 1095-8274 $g Roč. 61, č. - (2020), s. 102113
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31698044 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20210114154150 $b ABA008
- 999 __
- $a ok $b bmc $g 1608869 $s 1119714
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 61 $c - $d 102113 $e 20191104 $i 1095-8274 $m Anaerobe $n Anaerobe $x MED00006567
- LZP __
- $a Pubmed-20210105